QHSLab Modifies Debt and Converts Note to Equity

An update from QHSLab ( (USAQ) ) is now available.

On December 31, 2025, QHSLab, Inc. entered into a Promissory Note Modification and Partial Conversion Agreement with creditor Alex Mirakian MD PA, under which $126,548 of a previously issued convertible note’s principal and accrued interest was converted into 421,827 shares of QHSLab common stock at $0.30 per share, leaving $20,000 outstanding. The company extended the maturity date of the remaining balance to December 31, 2026, kept the original conversion features on the residual debt, and preserved the right to prepay without penalty, while issuing the new shares in a private, exempt transaction that reduces debt but dilutes existing shareholders and modestly strengthens QHSLab’s balance sheet.

The most recent analyst rating on (USAQ) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on QHSLab stock, see the USAQ Stock Forecast page.

Spark’s Take on USAQ Stock

According to Spark, TipRanks’ AI Analyst, USAQ is a Neutral.

The score is constrained primarily by weak financial quality—persistent net losses and a balance sheet with negative equity—despite improving revenue/margins and positive free cash flow. Technicals are a key offset with strong bullish momentum, while corporate actions (debt retirement and new equity financing) improve capital structure but do not fully remove the underlying risk profile; valuation remains challenging due to losses and no stated dividend yield.

To see Spark’s full report on USAQ stock, click here.

More about QHSLab

QHSLab, Inc. is a public company that issues common stock and uses convertible promissory notes as part of its financing structure, indicating a focus on capital markets instruments to support its operations and growth.

Average Trading Volume: 15,551

Technical Sentiment Signal: Buy

Current Market Cap: $6.84M

See more data about USAQ stock on TipRanks’ Stock Analysis page.